Advanced Leukemia Novel Drug Leads to ' Impressive ' Responses Advanced Leukemia Novel Drug Leads to ' Impressive ' Responses

The experimental menin inhibitor revumenib led to"deep and sustained remission" for two genetic subtypes of aggressive relapsed/refractory acute leukemia in the first-in-human trial.Medscape Medical News
Source: Medscape Hematology-Oncology Headlines - Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news